Literature DB >> 16584003

Comparison of functional parameters of constitutive and hypoxia-induced expression plasmids during acute ischemia of lower extremities.

N A Nikulina1, M V Kalashnikova, A V Belyavskii, N E Golantsova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16584003     DOI： 10.1134/s1607672906010091

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  15 in total

Review 1.  Gene transfer as a tool to induce therapeutic vascular growth.

Authors:  Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 2.  Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis.

Authors:  Stephen E Epstein; Eugenio Stabile; Timothy Kinnaird; Cheol Whan Lee; Leonardo Clavijo; Mary Susan Burnett
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 3.  Hydroxylation of HIF-1: oxygen sensing at the molecular level.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2004-08

Review 4.  Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.

Authors:  Seppo Ylä-Herttuala; Johanna E Markkanen; Tuomas T Rissanen
Journal:  Trends Cardiovasc Med       Date:  2004-11       Impact factor: 6.677

5.  Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.

Authors:  Luis G Melo; Reitu Agrawal; Lunan Zhang; Mojgan Rezvani; Abeel A Mangi; Afshin Ehsan; Daniel P Griese; Giorgio Dell'Acqua; Michael J Mann; Junichi Oyama; Shaw-Fang Yet; Matthew D Layne; Mark A Perrella; Victor J Dzau
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

6.  Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion.

Authors:  Y Tsurumi; S Takeshita; D Chen; M Kearney; S T Rossow; J Passeri; J R Horowitz; J F Symes; J M Isner
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

7.  Development of a hypoxia-responsive vector for tumor-specific gene therapy.

Authors:  T Shibata; A J Giaccia; J M Brown
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

8.  In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor.

Authors:  J Mühlhauser; R Pili; M J Merrill; H Maeda; A Passaniti; R G Crystal; M C Capogrossi
Journal:  Hum Gene Ther       Date:  1995-11       Impact factor: 5.695

Review 9.  Therapeutic angiogenesis using hepatocyte growth factor (HGF).

Authors:  Ryuichi Morishita; Motokuni Aoki; Naotaka Hashiya; Keita Yamasaki; Hitomi Kurinami; Shiro Shimizu; Hirofumi Makino; Yasushi Takesya; Junya Azuma; Toshio Ogihara
Journal:  Curr Gene Ther       Date:  2004-06       Impact factor: 4.391

10.  Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model.

Authors:  Hua Su; Janice Arakawa-Hoyt; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.